Head and Neck Cancer
Conditions
Keywords
serum squamous cell carcinoma antigen, tumor volume, Head and Neck Cancer
Brief summary
Correlation between serum squamous cell carcinoma antigen level and tumor volume in Head and Neck Cancer is to determine a correlation between level of serum squamous cell carcinoma antigen and tumor volume in Head and Neck Caner measured by cross-sectional imaging.
Detailed description
The study is a cross-sectional study. A single measurement of serum squamous cell carcinoma antigen level is performed in the eligible Head and Neck squamous cell carcinoma patients. The study tool measuring serum squamous cell carcinoma antigen level is ARCHITECT SCC (Abbott). The gross tumor volume in the cross sectional imaging obtained within 2 weeks of each patient is calculated with the typical ellipsoid formula. Correlation between both parameters will be determined.
Interventions
OTHERNon-interventional study
Sponsors
Prince of Songkla University
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Histologically proven squamous cell carcinoma in Head and Neck * Getting a cross-sectional imaging of Head and Neck within 2 weeks of collecting serum squamous cell carcinoma antigen
Exclusion criteria
* Metastatic disease * Accompanied Non-Head and Neck squamous cell carcinoma * Nasopharyngeal, thyroid, salivary, nose and paranasal sinus carcinoma * Skin disease: eczema, erythrodermic epidermitis, pemphigus, and psoriasis * Pulmonary disease: tuberculosis, adult respiratory distress syndrome, pulmonary infiltration with eosinophilia, sarcoidosis, and bronchogenic cyst * Renal failure * Using antihistamine eye drops
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between serum squamous cell carcinoma antigen and tumor volume | 2 weeks |
Countries
Thailand
Outcome results
None listed